欣旺達(300207.SZ):目前動力電池產品主要以三元為主,後續將根據市場需求調整,逐步轉變為以磷酸鐵鋰為主
格隆匯9月28日丨欣旺達(300207.SZ)於2023年9月27日接受特定對象調研,就“公司動力電池的增速情況”,公司表示,目前公司已相繼與國內外眾多知名汽車廠商建立了合作關係,未來將在維護現有客户的前提下積極開拓海外客户,對電動汽車電池產品增速有所提升。公司目前的動力電池產品主要以三元為主,後續將根據市場的需求來調整公司產品的結構,逐步轉變為以磷酸鐵鋰為主,以適應行業的需求與發展格局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.